Hematological Oncology : Impact Factor & More
eISSN: 1099-1069pISSN: 0278-0232
Share this on:
Key Metrics
CiteScore 
5.3
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Oncology
SNIP
1.04
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Hematological Oncology
Hematological Oncology Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1983 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Hematological Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hematological Oncology
Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study
- 1 Jan 2026
- Hematological Oncology
Title not available
- 1 Jan 2026
- Hematological Oncology
Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High-Dose Cytarabine-Based Chemotherapy as Second-Line Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- 1 Jan 2026
- Hematological oncology
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry.
- 1 Jan 2026
- Hematological oncology
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's Lymphoma.
- 1 Jan 2026
- Hematological oncology
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.
- 29 Dec 2025
- Hematological oncology
Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study
- 1 Jan 2026
- Hematological Oncology
Title not available
- 1 Jan 2026
- Hematological Oncology
Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High-Dose Cytarabine-Based Chemotherapy as Second-Line Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- 1 Jan 2026
- Hematological oncology
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry.
- 1 Jan 2026
- Hematological oncology
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's Lymphoma.
- 1 Jan 2026
- Hematological oncology
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.
- 29 Dec 2025
- Hematological oncology
FAQs on Hematological Oncology
How long has Hematological Oncology been actively publishing? 
What is the publishing frequency of Hematological Oncology?
How many articles did Hematological Oncology publish last year?
What is the eISSN & pISSN for Hematological Oncology?
What is Citescore for Hematological Oncology?
What is SNIP score for Hematological Oncology?
What is the SJR for Hematological Oncology?
Who is the publisher of Hematological Oncology?
